+9.5%
SNOW vs MRNA
+945.0%
-935.5%
-55.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.5% | +13.1% | -14.6% | -1.7% |
| 7D | -14.5% | +20.6% | -35.2% | -14.8% |
| 30D | -14.3% | +27.1% | -41.4% | -14.6% |
| 3M | -8.3% | +353.4% | -361.6% | -11.2% |
| 6M | +101.5% | +446.3% | -344.7% | +92.9% |
| YTD | +32.5% | +776.2% | -743.7% | +22.0% |
| 1Y | +9.5% | +987.9% | -978.4% | -2.8% |
| All | +9.5% | +945.0% | -935.5% | -2.8% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling